These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 15807873

  • 1. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, Lombardi G, Colao A, Filla A.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [Abstract] [Full Text] [Related]

  • 2. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT, Longo K, Manfredi M, Lucetti C, Cossu G, Petrone A, Marconi R, Sensi M, Epifanio A, Eleopra R, Marchese R, Scaravilli T, Morgante L, Abbruzzese G, Bonuccelli U, Donati E, Pivonello R, Colao A, Barone P.
    Mov Disord; 2008 Jan 30; 23(2):190-4. PubMed ID: 18044703
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia.
    Pellecchia MT, Salvatore E, Pivonello R, Faggiano A, Barone P, De Michele G, Colao AM, Filla A.
    Neurol Sci; 2001 Feb 30; 22(1):79-80. PubMed ID: 11487211
    [Abstract] [Full Text] [Related]

  • 4. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA, Kim BJ, Lee WY.
    Mov Disord; 2002 Nov 30; 17(6):1242-7. PubMed ID: 12465063
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN, Ginsberg JP, Hendell CD, Moshang T.
    Clin Endocrinol (Oxf); 2005 May 30; 62(5):628-32. PubMed ID: 15853837
    [Abstract] [Full Text] [Related]

  • 6. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia.
    Abdo WF, van de Warrenburg BP, Munneke M, van Geel WJ, Bloem BR, Kremer HP, Verbeek MM.
    Neurology; 2006 Aug 08; 67(3):474-9. PubMed ID: 16894110
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration.
    Strijks E, van't Hof M, Sweep F, Lenders JW, Oyen WJ, Horstink MW.
    J Neurol; 2002 Sep 08; 249(9):1206-10. PubMed ID: 12242540
    [Abstract] [Full Text] [Related]

  • 8. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease.
    Zhang K, Zeng Y, Song C, Fu Y, Wan Q.
    J Neurol; 2010 Sep 08; 257(9):1486-91. PubMed ID: 20405138
    [Abstract] [Full Text] [Related]

  • 9. Clonidine GH stimulation test to differentiate MSA from idiopathic late onset cerebellar ataxia: a prospective, controlled study.
    Bonnard C, Wirth T, Gebus O, Fahrer P, Montaut S, Robelin L, Tuzin N, Tranchant C, Anheim M.
    J Neurol; 2020 Mar 08; 267(3):855-859. PubMed ID: 32034477
    [Abstract] [Full Text] [Related]

  • 10. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
    Rouco I, Gómez JC, Lezcano E, Aniel-Quiroga MA, Velasco F, Barcena J, Pérez Bas M, Hurtado P, Cruz Lachén M, Zarranz JJ.
    Neurologia; 2006 Apr 08; 21(3):119-23. PubMed ID: 16575624
    [Abstract] [Full Text] [Related]

  • 11. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR, Watson L, Mathias CJ.
    Lancet; 1997 Jun 28; 349(9069):1877-81. PubMed ID: 9217760
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
    Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML.
    J Clin Endocrinol Metab; 2002 May 28; 87(5):2067-79. PubMed ID: 11994342
    [Abstract] [Full Text] [Related]

  • 13. Is clonidine-growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Mathias CJ, Kimber J, Watson L, Muthane U.
    J Neurol; 2002 Apr 28; 249(4):488-9. PubMed ID: 11967661
    [No Abstract] [Full Text] [Related]

  • 14. Arginine test is not reliable for diagnosing cerebellar multiple system atrophy.
    Gardner RC, Schmahmann JD.
    Ann Neurol; 2010 Mar 28; 67(3):404-8. PubMed ID: 20373353
    [Abstract] [Full Text] [Related]

  • 15. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E.
    Minerva Endocrinol; 1999 Mar 28; 24(3-4):107-11. PubMed ID: 10953725
    [Abstract] [Full Text] [Related]

  • 16. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G, Marzullo P, Ragusa L, Sartorio A, Trifirò G, Liuzzi A, Crinò A, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology.
    Clin Endocrinol (Oxf); 2006 Oct 28; 65(4):492-9. PubMed ID: 16984242
    [Abstract] [Full Text] [Related]

  • 17. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, Manners D, Zappia M, Morgante L, Barone P, Barbiroli B, Quattrone A.
    Brain; 2006 Oct 28; 129(Pt 10):2679-87. PubMed ID: 16815875
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone secretion in adult patients with thalassaemia.
    La Rosa C, De Sanctis V, Mangiagli A, Mancuso M, Guardabasso V, Galati MC, Caruso-Nicoletti M.
    Clin Endocrinol (Oxf); 2005 Jun 28; 62(6):667-71. PubMed ID: 15943827
    [Abstract] [Full Text] [Related]

  • 19. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
    Cianfarani S, Tondinelli T, Spadoni GL, Scirè G, Boemi S, Boscherini B.
    Clin Endocrinol (Oxf); 2002 Aug 28; 57(2):161-7. PubMed ID: 12153594
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC, Vestergaard P, Jakobsen PE, Falhof J, Laurberg P.
    J Clin Endocrinol Metab; 2000 Apr 28; 85(4):1467-72. PubMed ID: 10770183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.